Wikidata

(Q44045900)

English

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

scientific article published in July 2002

In more languages

Statements

title
Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
author name string
Oren Shibolet
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
Yaron Ilan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
Shmuel Gillis
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
Ayala Hubert
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
Daniel Shouval
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
Rifaat Safadi
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
publication date
1 July 2002
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017
page(s)
391-396
1 reference
stated in
Europe PubMed Central
PubMed ID
12091327
retrieved
29 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44045900&oldid=2105943392"